Sharon Lin

Principal Scientist @Ksq Therapeutics, Inc

Involved in decision making IND enabling studies for CRISPR enginered TIL cell therapy - Oversee and enable execution of all non-clinical activities including in vitro pharmacology and genotox safety for IND enabling studies- Secondary manager, manage a team of 3~4 - Cross-functional collaboration with in vivo team for IND enabling safety studies and MOA studies - Cross-functional collaboration with analytical development team and quality team for release assay development - Cross-functional collaboration with process development team and CMC team for process tech transfer